LG CNS Unveils Specialized Manufacturing AX Solutions for Pharma Industry at CPHI Milan 2026

The global pharmaceutical and biotech community is buzzing with excitement at the CPHI Milan 2026, where LG CNS has revealed its latest advancements in AI-driven manufacturing solutions tailored specifically for the pharmaceutical sector. As a leader in AI transformation based in Korea, LG CNS is poised to make significant waves in the industry with its innovative approaches to manufacturing processes.

Introduction to CPHI Milan

The CPHI, short for Convention on Pharmaceutical Ingredients, is recognized as the largest global trade fair for the pharmaceutical and biotech industries. Hosted at different international venues throughout the year, Milan's edition is particularly notable, attracting up to 60,000 attendees and around 3,000 companies from over 160 countries. This event stands as a critical platform for discovering the latest technologies and trends impacting the global pharmaceutical market.

LG CNS makes its mark as the only Korean company participating in the newly introduced “AI Tech” zone at this year's event, showcasing its commitment to leveraging technology in enhancing pharmaceutical manufacturing.

The Concept of an Autonomous Pharmaceutical Factory

The theme of LG CNS's exhibit is centered around the idea of an ‘Autonomous Factory’ within the pharmaceutical realm. The company is set to demonstrate three pioneering smart factory solutions that intricately connect factory design, operational processes, and quality management systems. These solutions are especially relevant for pharmaceutical and biotech firms looking to establish or expand their manufacturing facilities.

Smart Factory Solutions:

1. Factova Worldworks: This innovative tool serves as a digital twin simulation software that replicates real factory environments in a virtual setting. It allows potential users to visualize and analyze layouts for pharmaceutical production, effectively categorizing paths for staff and raw material transport. This level of detailed planning is crucial in preventing contamination among sensitive areas like clean rooms and production zones.

2. Factova Control: This sophisticated data standardization solution enhances operational control by automatically converting diverse process data—such as raw material IDs and formulations—into a uniform format. This real-time data standardization significantly improves responsiveness when new facilities come online or when existing processes undergo changes, ensuring streamlined operations.

3. Quality Management Solutions: Designed to proactively identify potential quality issues, this system analyzes critical production data, including temperature alterations and historical operational trends. If an anomaly is detected, it promptly assesses alternative measures to mitigate the problem, thereby reducing the chances of defective products reaching the market. Furthermore, an AI-powered agent simplifies the labor-intensive process of generating annual product quality reports, diminishing processing time by over 90%.

As highlighted by Eddie Jang, head of the Chemical and Battery Business at LG CNS, these solutions are meticulously designed to support pharmaceutical companies throughout their entire manufacturing journey—from facility planning and construction to stringent quality management. By implementing advanced automation, LG CNS aims to tackle the industry's challenges, particularly in maintaining the high precision and strict quality standards essential for pharmaceutical production.

Conclusion

The ambitious innovations presented by LG CNS at CPHI Milan 2026 not only underscore the company's prowess in AI transformation but also spotlight the potential for smart technology to revolutionize pharmaceutical manufacturing. As continuous advancements unfold, LG CNS remains committed to delivering comprehensive, intelligent automation solutions to its clients in the pharmaceutical and biotech sectors, enhancing their operational efficiency and product quality.

For more information, visit LG CNS.